Crossmark

TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma

Crossref DOI link: https://doi.org/10.1186/s13075-023-02994-z

Published Online: 2023-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mäki-Opas, Ilari

Hämäläinen, Mari

Moilanen, Eeva

Scotece, Morena
License Information

Text and Data Mining valid from 2023-01-25

Version of Record valid from 2023-01-25
More Information

Article History

Received: 2 June 2022

Accepted: 13 January 2023

First Online: 25 January 2023

Declarations

:

: Animal experiments were carried out in accordance with the EU legislation for the protection of animals used for scientific purposes (Directive 2010/63/EU), and the study was approved by the National Animal Experiment Board (ESAVI/24887/2020).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below